New Approved Treatment for Dupuytren's
I did a blog on Dupuytren's contracture last year that got a lot of interest. There are a lot of men out there with this condition and, apparently, many of them are reading EverythingHealth. I mentioned a new biologic drug that was being developed as a non-surgical treatment for Dupuytrens. At that time, it was still in testing phase and not available for use.
The product, collengenase clostridium histolyticum (Xiaflex) has now been approved and will be marketed by Auxilium Pharmaceuticas, Inc. It is injected directly into the palpable Dupuytren's cord, followed by a finger extension procedure 24 hours later to help distrupt the contracture cord.
The company plans to market Xiaflex to physicians experienced in hand injection procedures. The most common adverse reactions were fluid buildup, swelling, bleeding and pain in the injected area. No serious allergic reactions have been reported.